Back

Effects of potent P2Y12 inhibitors in patients who survived from acute myocardial infarction complicated by cardiogenic shock

14 March 2025 (08:45 - 18:30)
Organised by: Logo
Congress Presentation Part of: Innovation in acute heart failure: role of digital tools and impact of pharmacotherapy Antiplatelet Drugs ACVC Premium Access ESC Acute CardioVascular Care 2025 Association for Acute CardioVascular Care (ACVC)

About the speaker

Photo
Doctor Ki Hong Choi

Samsung Medical Center, Seoul (Korea (Republic of))

3 More presentations in this session

Presentation thumbnail
Qualitative evaluation of clinician interaction with a machine learning algorithm for the assessment of patients with suspected acute heart failure in the emergency department.
Doctor A. Ferry (Edinburgh, GB)
Abstract Slides
Presentation thumbnail
Association between AI-derived left ventricular longitudinal shortening and late gadolinium enhancement on CMR
Doctor R. Viana (Evora, PT)
Abstract Slides
Presentation thumbnail
AI-driven CMR assessment of atrial longitudinal shortening to evaluate left atrial function in HCM and MCD patients
Doctor R. Viana (Evora, PT)
Abstract Slides

Access the full session

Session thumbnail
Innovation in acute heart failure: role of digital tools and impact of pharmacotherapy

The Event

Event poster

ESC Acute CardioVascular Care 2025

14 March - 15 March 2025
You may be interested in
thumbnail
Congress Presentation
State-of-the-art lecture on pharmacotherapy for acute coronary syndromes
thumbnail
Webinar
Aspirin treatment for mitigating thrombotic risk across the cardiovascular risk continuum
thumbnail
Congress Presentation
Parenteral antiplatelet agents: when should they be used?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources